1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT results in increased expression of RIPK2 mRNA CTD PMID:22937105 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o, p'-DDT analog results in decreased expression of RIPK2 mRNA CTD PMID:22937105 17beta-estradiol affects expression ISO RGD:1319357 6480464 Estradiol affects the expression of RIPK2 mRNA CTD PMID:14699072 17beta-estradiol multiple interactions ISO RGD:1319357 6480464 Estradiol inhibits the reaction [Etoposide results in increased expression of RIPK2 mRNA] CTD PMID:19426747 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1319357 6480464 2 more ... CTD PMID:27589474 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of RIPK2 mRNA CTD PMID:19520675 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319358 6480464 Tetrachlorodibenzodioxin affects the expression of RIPK2 mRNA CTD PMID:21570461 2-methylcholine affects expression ISO RGD:1319357 6480464 beta-methylcholine affects the expression of RIPK2 mRNA CTD PMID:21179406 4,4'-diaminodiphenylmethane increases expression ISO RGD:1319358 6480464 4, 4'-diaminodiphenylmethane results in increased expression of RIPK2 mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide increases expression ISO RGD:1319358 6480464 Fenretinide results in increased expression of RIPK2 mRNA CTD PMID:28973697 6alpha-methylprednisolone decreases expression ISO RGD:1319357 6480464 Methylprednisolone results in decreased expression of RIPK2 mRNA CTD PMID:19192274 all-trans-retinoic acid increases expression ISO RGD:1319357 6480464 Tretinoin results in increased expression of RIPK2 mRNA CTD PMID:23724009 azathioprine decreases expression ISO RGD:1319357 6480464 Azathioprine results in decreased expression of RIPK2 mRNA CTD PMID:19192274 benzo[a]pyrene increases expression ISO RGD:1319358 6480464 Benzoapyrene results in increased expression of RIPK2 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1319357 6480464 Benzoapyrene results in increased expression of RIPK2 mRNA CTD PMID:26238291 bisphenol A decreases expression ISO RGD:1319357 6480464 bisphenol A results in decreased expression of RIPK2 mRNA CTD PMID:20678512 , PMID:29275510 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RIPK2 mRNA CTD PMID:25181051 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of RIPK2 mRNA CTD PMID:25993096 calcitriol increases expression ISO RGD:1319357 6480464 Calcitriol results in increased expression of RIPK2 mRNA CTD PMID:16002434 capsaicin increases expression ISO RGD:1319357 6480464 Capsaicin results in increased expression of RIPK2 mRNA CTD PMID:19502594 cholesterol multiple interactions EXP 6480464 6-hydroxy-2 more ... CTD PMID:19477266 cholesterol increases expression EXP 6480464 Cholesterol analog results in increased expression of RIPK2 mRNA CTD PMID:19477266 cisplatin increases expression ISO RGD:1319358 6480464 Cisplatin results in increased expression of RIPK2 mRNA CTD PMID:26546572 cisplatin decreases expression ISO RGD:1319357 6480464 Cisplatin results in decreased expression of RIPK2 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1319358 6480464 4-methyl-N1-3-phenylpropylbenzene-1, 2-diamine inhibits the reaction [Cisplatin results in increased expression of RIPK2 mRNA] CTD PMID:26546572 cobalt atom multiple interactions ISO RGD:1319357 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of RIPK2 mRNA CTD PMID:18078969 copper(II) sulfate increases expression ISO RGD:1319357 6480464 Copper Sulfate results in increased expression of RIPK2 mRNA CTD PMID:19549813 crocidolite asbestos affects expression ISO RGD:1319357 6480464 Asbestos, Crocidolite affects the expression of RIPK2 mRNA CTD PMID:24160326 cyclosporin A increases expression ISO RGD:1319357 6480464 Cyclosporine results in increased expression of RIPK2 mRNA CTD PMID:20106945 , PMID:25562108 DDE affects expression EXP 6480464 Dichlorodiphenyl Dichloroethylene affects the expression of RIPK2 mRNA CTD PMID:24576310 deoxynivalenol increases expression ISO RGD:1319358 6480464 deoxynivalenol results in increased expression of RIPK2 mRNA CTD PMID:22968694 dicrotophos decreases expression ISO RGD:1319357 6480464 dicrotophos results in decreased expression of RIPK2 mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of RIPK2 mRNA CTD PMID:22546817 doxorubicin affects response to substance ISO RGD:1319357 6480464 RIPK2 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression ISO RGD:1319357 6480464 Doxorubicin results in decreased expression of RIPK2 mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO RGD:1319357 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RIPK2 protein CTD PMID:23301498 ethanol affects expression ISO RGD:1319358 6480464 Ethanol affects the expression of RIPK2 mRNA CTD PMID:30319688 etoposide multiple interactions ISO RGD:1319357 6480464 Estradiol inhibits the reaction [Etoposide results in increased expression of RIPK2 mRNA] CTD PMID:19426747 etoposide increases expression ISO RGD:1319357 6480464 Etoposide results in increased expression of RIPK2 mRNA CTD PMID:19426747 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of RIPK2 mRNA CTD PMID:23962444 fluoranthene multiple interactions ISO RGD:1319358 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of RIPK2 mRNA CTD PMID:28329830 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of RIPK2 mRNA CTD PMID:24793618 folic acid increases expression ISO RGD:1319358 6480464 Folic Acid results in increased expression of RIPK2 mRNA CTD PMID:25629700 furan increases expression EXP 6480464 furan results in increased expression of RIPK2 mRNA CTD PMID:22079235 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of RIPK2 mRNA CTD PMID:22061828 lamivudine multiple interactions ISO RGD:1319357 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of RIPK2 mRNA CTD PMID:15784690 lead(0) affects expression ISO RGD:1319357 6480464 Lead affects the expression of RIPK2 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1319357 6480464 Lead affects the expression of RIPK2 mRNA CTD PMID:28903495 lipopolysaccharide increases expression ISO RGD:1319358 6480464 Lipopolysaccharides results in increased expression of RIPK2 mRNA CTD PMID:20423518 more ... lipopolysaccharide multiple interactions ISO RGD:1319358 6480464 methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of RIPK2 mRNA], phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of RIPK2 mRNA] CTD PMID:20423518 , PMID:24056979 metam multiple interactions ISO RGD:1319358 6480464 methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased expression of RIPK2 mRNA] CTD PMID:24056979 metformin multiple interactions ISO RGD:1319357 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of RIPK2 mRNA CTD PMID:29309887 methotrexate decreases expression ISO RGD:1319357 6480464 Methotrexate results in decreased expression of RIPK2 mRNA CTD PMID:19192274 methylisothiazolinone increases expression ISO RGD:1319357 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of RIPK2 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1319357 6480464 methylmercuric chloride results in increased expression of RIPK2 mRNA CTD PMID:28001369 Mitotane increases expression EXP 6480464 Mitotane results in increased expression of RIPK2 mRNA CTD PMID:23485034 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cholesterol analog results in increased expression of RIPK2 mRNA] CTD PMID:19477266 nickel dichloride increases expression ISO RGD:1319357 6480464 nickel chloride results in increased expression of RIPK2 mRNA CTD PMID:17312168 nickel sulfate increases expression ISO RGD:1319357 6480464 nickel sulfate results in increased expression of RIPK2 mRNA CTD PMID:22714537 ochratoxin A decreases expression ISO RGD:1319357 6480464 ochratoxin A results in decreased expression of RIPK2 mRNA CTD PMID:29098329 ochratoxin A multiple interactions ISO RGD:1319357 6480464 [ochratoxin A results in decreased acetylation of RIPK2 promoter] which results in decreased expression of RIPK2 mRNA CTD PMID:29098329 ochratoxin A decreases acetylation ISO RGD:1319357 6480464 ochratoxin A results in decreased acetylation of RIPK2 promoter CTD PMID:29098329 p-menthan-3-ol increases expression ISO RGD:1319357 6480464 Menthol results in increased expression of RIPK2 mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO RGD:1319357 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of RIPK2 mRNA CTD PMID:29309887 paraquat increases expression ISO RGD:1319357 6480464 Paraquat results in increased expression of RIPK2 mRNA CTD PMID:18836921 perfluorononanoic acid increases expression ISO RGD:1319357 6480464 perfluorononanoic acid results in increased expression of RIPK2 mRNA CTD PMID:32588087 phenethyl isothiocyanate multiple interactions ISO RGD:1319358 6480464 phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of RIPK2 mRNA] CTD PMID:20423518 phenobarbital affects expression ISO RGD:1319357 6480464 Phenobarbital affects the expression of RIPK2 mRNA CTD PMID:19159669 pirinixic acid multiple interactions ISO RGD:1319357 6480464 pirinixic acid inhibits the reaction [IL1B protein results in increased expression of RIPK2 mRNA], pirinixic acid inhibits the reaction [TNF protein results in increased expression of RIPK2 mRNA] CTD PMID:19693652 pirinixic acid multiple interactions ISO RGD:1319358 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RIPK2 mRNA CTD PMID:19710929 piroxicam decreases expression ISO RGD:1319357 6480464 Piroxicam results in decreased expression of RIPK2 mRNA CTD PMID:19192274 prednisolone decreases expression ISO RGD:1319357 6480464 Prednisolone results in decreased expression of RIPK2 mRNA CTD PMID:19192274 propylparaben increases expression ISO RGD:1319357 6480464 propylparaben results in increased expression of RIPK2 mRNA CTD PMID:24481588 quercetin increases expression ISO RGD:1319357 6480464 Quercetin results in increased expression of RIPK2 mRNA CTD PMID:21632981 serpentine asbestos affects expression ISO RGD:1319357 6480464 Asbestos, Serpentine affects the expression of RIPK2 mRNA CTD PMID:24160326 silicon dioxide increases expression ISO RGD:1319358 6480464 Silicon Dioxide results in increased expression of RIPK2 mRNA CTD PMID:23221170 sodium arsenite multiple interactions ISO RGD:1319357 6480464 CHEK2 protein affects the reaction [sodium arsenite results in increased expression of RIPK2 mRNA modified form], ELAVL1 protein affects the reaction [sodium arsenite results in increased expression of RIPK2 mRNA modified form] CTD PMID:24865968 sodium arsenite increases expression ISO RGD:1319357 6480464 sodium arsenite results in increased expression of RIPK2 mRNA, sodium arsenite results in increased expression of RIPK2 mRNA modified form CTD PMID:24865968 sodium aurothiomalate decreases expression ISO RGD:1319357 6480464 Gold Sodium Thiomalate results in decreased expression of RIPK2 mRNA CTD PMID:19192274 Soman increases expression EXP 6480464 Soman results in increased expression of RIPK2 mRNA CTD PMID:19281266 sulfasalazine multiple interactions ISO RGD:1319357 6480464 Sulfasalazine inhibits the reaction [TNF protein results in increased expression of RIPK2 mRNA] CTD PMID:19693652 tert-butyl hydroperoxide increases expression ISO RGD:1319357 6480464 tert-Butylhydroperoxide results in increased expression of RIPK2 mRNA CTD PMID:15336504 thapsigargin decreases expression ISO RGD:1319358 6480464 Thapsigargin results in decreased expression of RIPK2 protein CTD PMID:24648495 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RIPK2 mRNA CTD PMID:23411599 titanium dioxide decreases expression ISO RGD:1319358 6480464 titanium dioxide results in decreased expression of RIPK2 mRNA CTD PMID:29264374 topotecan affects response to substance ISO RGD:1319357 6480464 RIPK2 protein affects the susceptibility to Topotecan CTD PMID:16217747 Triptolide increases expression EXP 6480464 triptolide results in increased expression of RIPK2 protein CTD PMID:32519852 troglitazone increases expression ISO RGD:1319357 6480464 troglitazone results in increased expression of RIPK2 mRNA CTD PMID:19140230 Tungsten carbide multiple interactions ISO RGD:1319357 6480464 [tungsten carbide co-treated with Cobalt] results in decreased expression of RIPK2 mRNA CTD PMID:18078969 tunicamycin increases expression ISO RGD:1319357 6480464 Tunicamycin results in increased expression of RIPK2 mRNA CTD PMID:22378314 urethane increases expression ISO RGD:1319357 6480464 Urethane results in increased expression of RIPK2 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1319358 6480464 Valproic Acid results in increased expression of RIPK2 mRNA CTD PMID:21427059 valproic acid increases expression ISO RGD:1319357 6480464 Valproic Acid results in increased expression of RIPK2 mRNA CTD PMID:23179753 valproic acid decreases methylation ISO RGD:1319357 6480464 Valproic Acid results in decreased methylation of RIPK2 gene CTD PMID:29154799 vincristine increases expression ISO RGD:1319357 6480464 Vincristine results in increased expression of RIPK2 mRNA CTD PMID:23649840 zidovudine multiple interactions ISO RGD:1319357 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of RIPK2 mRNA CTD PMID:15784690 zinc oxide multiple interactions ISO RGD:1319358 6480464 Zinc Oxide affects the splicing of and results in increased expression of RIPK2 mRNA CTD PMID:30500950 zoledronic acid increases expression ISO RGD:1319357 6480464 zoledronic acid results in increased expression of RIPK2 mRNA CTD PMID:24714768